Ignite Creation Date:
2024-05-06 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03671564
Status:
COMPLETED
Last Update Posted:
2023-11-07
First Post:
2018-09-04
Brief Title:
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Daiichi Sankyo Co Ltd
Organization:
Daiichi Sankyo
Organization Data
Organization:
Daiichi Sankyo
Class:
INDUSTRY
Study ID:
DS3032-A-J104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daiichi Sankyo Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None